Chemed (NYSE:CHE) - Hisse Senedi Fiyatı, Haberler ve Analizler

Bu sayfanın çevirisi deneyseldir ve geliştirilme aşamasındadır. imlerinizi bekliyoruz!

CHE Stoklara Genel Bakış

CHE temel anali̇z
Kar Tanesi Skoru
Değerleme	1/6
Gelecekteki Büyüme	1/6
Geçmiş Performans	6/6
Finansal Sağlık	6/6
Temettüler	0/6

Ödüller

Kazançların yılda 13.25% oranında artması öngörülüyor

Kazançlar geçen yıl 32.9% oranında arttı

Risk Analizi

Son 3 ayda önemli miktarda içeriden satış gerçekleşti

Community Narratives

Create a narrative

Narratives bring a range of perspectives from our community.

WarrenAI

Based on Analyst Price Targets

Strategic Acquisitions And Operational Efficiencies Set To Propel VITAS And Roto-Rooter Forward

US$685.00

14.6% undervalued

7.20%

Revenue growth p.a.

1 day ago

Chemed Corporation Rakipler

DaVita

NYSE:DVA

US$13.3b

CorVel

NasdaqGS:CRVL

US$5.5b

Option Care Health

NasdaqGS:OPCH

US$5.1b

Quest Diagnostics

NYSE:DGX

US$17.2b

Fiyat Geçmişi ve Performans

için tüm zamanların en yüksek seviyelerinin, değişikliklerin ve fiyat düşüşlerinin özeti Chemed
Tarihsel hisse senedi fiyatları
Güncel Hisse Fiyatı	US$585.27
52 Haftanın En Yüksek Seviyesi	US$654.62
52 Haftanın En Düşük Seviyesi	US$497.37
Beta	0.44
11 Aylık Değişim	0.065%
3 Aylık Değişim	8.78%
1 Yıllık Değişim	14.64%
33 Yıllık Değişim	39.19%
5 Yıllık Değişim	41.54%
Halka arzdan bu yana değişim	5,073.66%

Son Haberler & Güncellemeler

Capital Investments At Chemed (NYSE:CHE) Point To A Promising Future

Aug 26

Recent updates

Here's Why Chemed Corporation's (NYSE:CHE) CEO Compensation Is The Least Of Shareholders' Concerns

May 14

Is Chemed Corporation (NYSE:CHE) Trading At A 50% Discount?

Apr 26

Chemed Corporation (NYSE:CHE) Full-Year Results: Here's What Analysts Are Forecasting For This Year

Mar 01

The Price Is Right For Chemed Corporation (NYSE:CHE)

Dec 30

Chemed: Continues To Compound Shareholder Value At Double-Digit Returns

Nov 30

Chemed (NYSE:CHE) Is Aiming To Keep Up Its Impressive Returns

Oct 26

Chemed - Showcasing Why It's So Reliable

Aug 26

Chemed: Still Bullish On Economic Characteristics, But Risks Shouldn't Be Overlooked

Aug 13

Is Chemed Corporation (NYSE:CHE) Worth US$521 Based On Its Intrinsic Value?

Aug 01

Capital Investments At Chemed (NYSE:CHE) Point To A Promising Future

Jul 14

Chemed (NYSE:CHE) Has A Rock Solid Balance Sheet

Jun 07

Chemed (NYSE:CHE) Is Aiming To Keep Up Its Impressive Returns

Apr 09

Chemed Q4 2022 Earnings Preview

Feb 22

Chemed Corporation: Long-Term Tailwinds, But Remains A Hold

Feb 14

Is Chemed (NYSE:CHE) Using Too Much Debt?

Jan 05

Here's What Chemed's (NYSE:CHE) Strong Returns On Capital Mean

Dec 17

Chemed declares $0.38 dividend

Nov 04

Chemed Q3 2022 Earnings Preview

Oct 28

Does Chemed (NYSE:CHE) Have A Healthy Balance Sheet?

Oct 01

Capital Investment Trends At Chemed (NYSE:CHE) Look Strong

Sep 16

Buy Chemed To Reduce Equity Beta And Stabilize Portfolio Returns

Aug 26

A Look At The Intrinsic Value Of Chemed Corporation (NYSE:CHE)

Aug 16

Hissedar Getirileri

	CHE	US Healthcare	US Pazar
7D	-2.5%	-0.2%	-0.4%
1Y	14.6%	10.8%	34.1%

Getiri vs. Endüstri: CHE geçen yıl % 10.8 oranında getiri sağlayan US Healthcare sektörünü aştı.

Getiri vs Piyasa: CHE geçen yıl % 34.1 oranında getiri sağlayan US Piyasasının altında performans gösterdi.

Fiyat Oynaklığı

Is CHE's price volatile compared to industry and market?
CHE volatility
CHE Average Weekly Movement	2.5%
Healthcare Industry Average Movement	7.0%
Market Average Movement	6.4%
10% most volatile stocks in US Market	14.9%
10% least volatile stocks in US Market	3.1%

İstikrarlı Hisse Senedi Fiyatı: CHE son 3 ayda önemli bir fiyat oynaklığı yaşamadı.

Zaman İçindeki Volatilite: CHE 'nin haftalık oynaklığı ( 2% ) son bir yıldır istikrarlı seyretti.

Şirket Hakkında

Kuruldu	Çalışanlar	CEO	Web sitesi
1970	15,087	Kevin McNamara	www.chemed.com

Chemed Corporation, öncelikle Amerika Birleşik Devletleri'nde doktorlar, kayıtlı hemşireler, evde sağlık yardımcıları, sosyal hizmet uzmanları, din adamları ve gönüllülerden oluşan bir ağ aracılığıyla hastalara hospis ve palyatif bakım hizmetleri sunmaktadır. Şirket, VITAS ve Roto-Rooter segmentlerinde faaliyet göstermektedir. Şirkete ait şubeler, bağımsız yükleniciler ve bayiler aracılığıyla konut ve ticari müşterilere sıhhi tesisat, drenaj temizliği, kazı, su restorasyonu ve diğer ilgili hizmetleri sunmaktadır.

Chemed Corporation Temel Bilgiler Özeti

Chemed'un kazançları ve gelirleri piyasa değeriyle nasıl karşılaştırılır?
CHE temel i̇stati̇sti̇kler
Piyasa değeri	US$8.89b
Kazançlar(TTM)	US$300.92m
Gelir(TTM)	US$2.34b

29.2x

F/K Oranı

3.8x

P/S Oranı

CHE aşırı değerli mi?

Gerçeğe Uygun Değer ve değerleme analizine bakınız

Kazanç ve Gelir

En son kazanç raporundan temel karlılık istatistikleri (TTM)
CHE gelir tablosu (TTM)
Gelir	US$2.34b
Gelir Maliyeti	US$1.50b
Brüt Kâr	US$839.98m
Diğer Giderler	US$539.06m
Kazançlar	US$300.92m

Son Raporlanan Kazançlar

Jun 30, 2024

Sonraki Kazanç Tarihi

Oct 29, 2024

Hisse başına kazanç (EPS)	20.07
Brüt Marj	35.96%
Net Kâr Marjı	12.88%
Borç/Özkaynak Oranı	0%

CHE uzun vadede nasıl bir performans gösterdi?

Geçmiş performansı ve karşılaştırmayı görün

Temettüler

0.3%

Mevcut Temettü Verimi

8%

Ödeme Oranı

CHE Stoklara Genel Bakış

Ödüller

Risk Analizi

Strategic Acquisitions And Operational Efficiencies Set To Propel VITAS And Roto-Rooter Forward

Chemed Corporation Rakipler

NYSE:DVA

US$13.3b

NasdaqGS:CRVL

US$5.5b

NasdaqGS:OPCH

US$5.1b

NYSE:DGX

US$17.2b

Fiyat Geçmişi ve Performans

Son Haberler & Güncellemeler

CEO, President & Director recently sold US$1.2m worth of stock

Chemed Corporation to Report Q3, 2024 Results on Oct 29, 2024

Executive Vice President recently sold US$975k worth of stock

Executive Vice President exercised options and sold US$1.6m worth of stock

Capital Investments At Chemed (NYSE:CHE) Point To A Promising Future

Recent updates

CEO, President & Director recently sold US$1.2m worth of stock

Chemed Corporation to Report Q3, 2024 Results on Oct 29, 2024

Executive Vice President recently sold US$975k worth of stock

Executive Vice President exercised options and sold US$1.6m worth of stock

Capital Investments At Chemed (NYSE:CHE) Point To A Promising Future

Chemed Remains A Buy On Long-Term Economics

VP & Director notifies of intention to sell stock

Second quarter dividend increased to US$0.50

Chemed Corporation Declares Quarterly Dividend, Payable on August 30, 2024

Executive Vice President recently sold US$1.1m worth of stock

Executive Vice President notifies of intention to sell stock

Second quarter 2024 earnings: EPS misses analyst expectations

Chemed Corporation's (NYSE:CHE) Shares May Have Run Too Fast Too Soon

Chemed Corporation to Report Q2, 2024 Results on Jul 24, 2024

CEO, President & Director recently sold US$816k worth of stock

CEO, President & Director notifies of intention to sell stock

First quarter dividend of US$0.40 announced

Chemed Corporation Declares Quarterly Dividend, Payable on June 18, 2024

Chemed: Growth Does Not Justify The Current Stock Price

CEO, President & Director recently sold US$2.3m worth of stock

Here's Why Chemed Corporation's (NYSE:CHE) CEO Compensation Is The Least Of Shareholders' Concerns

Is Chemed Corporation (NYSE:CHE) Trading At A 50% Discount?

Chemed Corporation Reiterates Earnings Guidance for Full Year 2024

First quarter 2024 earnings: EPS misses analyst expectations

Chemed Corporation, Annual General Meeting, May 20, 2024

New major risk - Revenue and earnings growth

Executive Vice President exercised options and sold US$3.8m worth of stock

Executive Vice President recently sold US$1.3m worth of stock

Chemed Corporation to Report Q1, 2024 Results on Apr 24, 2024

Price target increased by 10% to US$690

Chemed Corporation (NYSE:CHE) Full-Year Results: Here's What Analysts Are Forecasting For This Year

Full year 2023 earnings: Revenues and EPS in line with analyst expectations

Now 22% overvalued after recent price rise

Third quarter dividend of US$0.40 announced

Chemed Corporation Declares Quarterly Dividend, Payable on March 15, 2024

Chemed Corporation to Report Q4, 2023 Results on Feb 27, 2024

The Price Is Right For Chemed Corporation (NYSE:CHE)

Chemed Corporation Appoints Michael D. Witzeman as Chief Financial Officer, Effective January 1, 2024

CEO, President & Director recently sold US$859k worth of stock

Chemed: Continues To Compound Shareholder Value At Double-Digit Returns

Executive Vice President recently sold US$580k worth of stock

Executive VP & CFO notifies of intention to sell stock

Chemed Corporation Announces the Retirement of David P. Williams as Chief Financial Officer Effective December 31, 2023

Chemed Corporation Announces the Retirement of David P. Williams as Chief Financial Officer Effective December 31, 2023

Executive VP & CFO exercised options to buy US$5.9m worth of stock.

CEO, President & Director recently sold US$1.7m worth of stock

Chemed Corporation Provides Earnings Guidance for the Full-Year 2023

Third quarter 2023 earnings: EPS and revenues exceed analyst expectations

Chemed (NYSE:CHE) Is Aiming To Keep Up Its Impressive Returns

Chemed Corporation to Report Q3, 2023 Results on Oct 25, 2023

Chemed - Showcasing Why It's So Reliable

Chemed: Still Bullish On Economic Characteristics, But Risks Shouldn't Be Overlooked

CEO, President & Director recently sold US$2.1m worth of stock

Is Chemed Corporation (NYSE:CHE) Worth US$521 Based On Its Intrinsic Value?

Second quarter 2023 earnings: EPS and revenues miss analyst expectations

Capital Investments At Chemed (NYSE:CHE) Point To A Promising Future

Chemed Corporation to Report Q2, 2023 Results on Jul 26, 2023

Chemed (NYSE:CHE) Has A Rock Solid Balance Sheet

Executive Vice President notifies of intention to sell stock